National Institute of Biomedical Imaging and Bioengineering

Funds biomedical imaging and engineering innovation through NIBIB grants, centers, and partnerships to enable earlier diagnosis and treatment tools.

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is a NIH institute within the Department of Health and Human Services. Its mission is to transform disease understanding and care through technology development, and it backs biomedical imaging and engineering that improve prevention, detection, diagnosis, and treatment.

NIBIB funds MRI, CT, ultrasound, PET, optical imaging, tissue engineering, biomaterials, biosensors, informatics, digital health, and SBIR/STTR. Its routes include the Trailblazer R21 up to $400,000, Bioengineering Partnerships with Industry up to $600,000, the P41 National Centers program up to $2 million, the Small Grant Program up to $50,000, and NIBIB SBIR up to $2 million.

Its work is designed to cross disease boundaries, so a platform that can support cancer, cardiovascular, neuroscience, or other clinical areas fits naturally. Applicants do best when the proposal is clearly enabling technology, shows a credible translation path, and can explain why NIBIB is the right home instead of a disease-specific institute.